Back
FT Value Line® Dividend ETF CAD Hdg Comm Vs. Aligos Therapeutics Industry Stock Comparison
Sell
44
FUD.TO
FT Value Line® Dividend ETF CAD Hdg Comm
Last Price:
36.89
Seasonality Move:
1.05%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.48
Seasonality Move:
10.65%
Sell
44
FT Value Line® Dividend ETF CAD Hdg Comm (FUD.TO)
is a Sell
Is FT Value Line® Dividend ETF CAD Hdg Comm a Buy, Sell or Hold?
- The current FT Value Line® Dividend ETF CAD Hdg Comm [FUD.TO] share price is $36.89. The Score for FUD.TO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- FUD.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FUD.TO Stock Price Chart
What is FT Value Line® Dividend ETF CAD Hdg Comm's stock price today?
-
The FT Value Line® Dividend ETF CAD Hdg Comm share price today is $36.89
The current trend is moderately bearish and FUD.TO is experiencing slight buying pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FUD.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 42.9 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.61 - 37.41) | Sell |
Bollinger Bands (100): | (34.68 - 37.26) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.71 | Buy |
Relative Strength Index (14 RSI): | 85.17 | Buy |
Chaikin Money Flow: | 491004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.08 - 27.66) | Buy |
Bollinger Bands (100): | (7.67 - 19.61) | Buy |
FUD.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.3 | Sell |
20-day SMA: | 37.09 | Sell |
50-day SMA: | 36.85 | Buy |
200-day SMA: | 34.72 | Buy |
8-day EMA: | 37.15 | Sell |
20-day EMA: | 37.1 | Sell |
50-day EMA: | 36.76 | Buy |
200-day EMA: | 35.07 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.48 | Buy |
20-day SMA: | 23.64 | Buy |
50-day SMA: | 14.76 | Buy |
200-day SMA: | 15.86 | Buy |
8-day EMA: | 28.77 | Buy |
20-day EMA: | 23.99 | Buy |
50-day EMA: | 18.16 | Buy |
200-day EMA: | 16.13 | Buy |
FT Value Line® Dividend ETF CAD Hdg Comm Earnings Growth & FUD.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
FT Value Line® Dividend ETF CAD Hdg Comm Technical Analysis
Nov 28 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
28 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |